Cell & Gene Therapy Bioprocessing & Commercialization is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Shashi Murthy is a Professor of Chemical Engineering at Northeastern University. He is an expert in the areas of cell separation and automated cell culture and current projects in his lab focus on patient-specific dendritic cell generation and dendritic cell-mediated T cell expansion for therapeutic use. Prof. Murthy earned his Ph.D. in Materials Science & Engineering at the Massachusetts Institute of Technology (MIT) in 2003 and his B.S. in Chemical Engineering at Johns Hopkins University in 1999. He joined Northeastern in 2005 following a postdoctoral fellowship at the Harvard Medical School and Massachusetts General Hospital.
Prof. Murthy is the recipient of the National Science Foundation’s Faculty Early Career Development (CAREER) Award, the Søren Buus Award for Outstanding Research in Engineering at Northeastern University and is an elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE). Prof. Murthy has co-authored over 70 publications and is an inventor on 8 issued or pending patents. He co-founded Quad Technologies, acquired in 2018 by Bio-Techne, which commercialized hydrogel technology developed in his lab for releasable bead-based cell separation and T cell activation. More recently he founded Flaskworks, which is commercializing automated cell culture systems for dendritic cell-based immunotherapies.